Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07189819 · ClinicalTrials.gov registry record · NA
Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait
A NA study, sponsored by Emory University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07189819: Clinical Trial NA study, sponsored by Emory University.
NCT07189819 is a NA study that has not yet begun recruiting, run by Emory University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07189819, a NA study, has not yet begun recruiting, sponsored by Emory University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will compare the performance of a novel data-driven model-predictive controller (MPC) based functional electrical stimulation (FES) system versus a conventional FES system for footdrop correction during treadmill and overground walking tasks in people post-stroke.
Primary Outcome
Safety is assessed as the number of adverse events experienced by study participants.
Interventions
- DEVICE Model-Predictive Controller (MPC) Functional Electrical Stimulation (FES)
- DEVICE Conventional Functional Electrical Stimulation (FES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What is known before NCT07189819 opens enrollment
NCT07189819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Model-Predictive Controller (MPC) Functional Electrical Stimulation (FES) is the first listed.
NCT07189819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07189819 about?
NCT07189819 is a clinical study titled "Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait". This study will compare the performance of a novel data-driven model-predictive controller (MPC) based functional electrical stimulation (FES) system versus a conventional FES system for footdrop correction during treadmill and overground walking tasks in people post-stroke.
What is the current status of trial NCT07189819?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06-01. Estimated completion is 2026-12-01.
What interventions are being tested in trial NCT07189819?
The interventions under investigation include: Model-Predictive Controller (MPC) Functional Electrical Stimulation (FES) (DEVICE), Conventional Functional Electrical Stimulation (FES) (DEVICE).
Who is sponsoring clinical trial NCT07189819?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07189819's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI